Telomerase activity in primary and secondary glioblastomas multiforme as a novel molecular tumor marker

Journal of Neurosurgery

Volumn 93, Issue 4, 2000, Pages 618-625

  Harada, Kunyu ^b   Kurisu, Kaoru ^b   Tahara, Hidetoshi ^b   Tahara, Eiji ^b   Ide, Toshinori ^b   Tahara, Eiichi ^b  

^a Department of Neurosurgery   (Japan)

^b NONE

Author keywords

Epidermal growth factor receptor; Glioblastoma multiforme; p53; Telomerase

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53; TELOMERASE; TUMOR MARKER;

ARTICLE; CARCINOGENESIS; CHROMOSOME 10; CHROMOSOME 17P; DIAGNOSTIC VALUE; ENZYME ACTIVITY; GENE MUTATION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL;

EID: 0034433730     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.2000.93.4.0618     Document Type: Article

References (45)

1. Assay formats involving acridinium-ester-labeled DNA probes
2. The association between telomerase, p53, and clinical staging in colorectal cancer
3. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis
4. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
5. Telomerase activity in normal leukocytes and in hematologic malignancies
6. The RNA component of human telomerase
7. Detection of BCL-6 rearrangements and p53 mutations in malt-lymphomas
8. p53 point mutation and survival in colorectal cancer patients
9. Telomerase activity in central nervous system malignant lymphoma
10. Telomerase activity in human brain tumors
11. Telomeres shorten during ageing of human fibroblasts
12. Telomeres and telomerase in aging and cancer
13. Telomerase activity and alterations in telomere length in human brain tumors
14. A rapid, useful and quantative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol
15. Telomerase activity in human breast tumors
16. Correlating telomerase activity levels with human neuroblastoma outcomes
17. Role of telomerase in cellular proliferation and cancer
18. Telomere crisis, the driving force in cancer cell evolution
19. Association of p53 gene mutation with decreased chemosensitivity in human malignant gliomas
20. Oncogene alterations in carcinomas of the uterine cervix: Overexpression of the epidermal growth factor receptor is associated with poor prognosis
21. Specific association of human telomerase activity with immortal cells and cancer
22. Genetics of glioma progression and the definition of primary and secondary glioblastoma
23. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labeling
24. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
25. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors
26. Telomerase activity in human brain tumours
27. mdm2 gene alterations and mdm2 protein expression in breast carcinomas
28. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
29. Telomerase catalytic subunit homologs from fission yeast and human
30. TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family
31. Telomerase activation by hTRT in human normal fibroblast and hepatocellular carcinomas
32. Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer
33. Analysis of the p53 and MDM-2 gene in acute myeloid leukemia
34. Telomerase in human development and cancer
35. Telomere shortening may contribute to aging and cancer: A perspective
36. Defining the molecular mechanisms of human cell immortalization
37. Telomerase activity in gastric and colorectal carcinomas correlates well with malignant progression
38. Telomerase activity in human liver tissues: Comparison between chronic liver disease and hepatocellular carcinomas
39. Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus
40. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells
41. The multistep nature of cancer
42. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies
43. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas